ATTRACTION-5
ATTRACTION-5: Phase III Study of Adjuvant Nivolumab + Chemotherapy After Gastrectomy for Pathologic Stage III Gastric or Gastroesophageal Junction Cancer

Released: June 04, 2023

Activity

Progress
1
Course Completed